(Bloomberg) -- Wall Street kicked off a pivotal week with the dollar climbing the most since May as a tariff deal between President Donald Trump and the...
After last week's meme stock rally, Monday has kicked off with a wild surge in the shares of a tiny vape company on plans it will start amassing crypto.
The more than one million messages obtained by 404 Media are as recent as last week, discuss incredibly sensitive topics, and make it trivial to unmask some anonymous Tea users.
A movement is growing to bring small, portable, affordable solar to a balcony or backyard near you. But before you see them everywhere, advocates must break through significant barriers.
Temu users are “very likely” to find items violating EU rules against unsafe or counterfeit products, according to preliminary findings from the European Commission’s investigation.
The U.S. Space Force, in partnership with the Air Force Rapid Capabilities Office, is scheduled to launch the eighth mission of the X-37B Orbital Test Vehicle (OTV-8) on Aug. 21, 2025, from Kennedy
The US housing market just logged its slowest spring season in more than a dozen years, leaving Glennda Baker, a veteran real estate agent in Atlanta, struggling to sell 21 listings.
Senator Patty Murray says electricity bills in Washington state will go up because of the so-called "One Big Beautiful Bill," which cut federal spending on renewable energy projects.
So is it true? And if so, why?
This week, several major companies will be reporting earnings. Among them are Apple (AAPL), Amazon (AMZN), Microsoft (MSFT), Meta Platforms (META), PayPal Holdings ...
A Hong Kong conglomerate that’s selling ports at the Panama Canal says it may seek a Chinese investor to join a consortium of buyers. The could please Beijing but could also bring more U.S. scrutiny to a geopolitically fraught deal. CK Hutchison Holdings's in…
A phase 3 trial of Celcuity’s breast cancer combination has hit its primary endpoints, blasting past the biotech’s bar for success to tee up a filing for FDA approval in the fourth quarte | A phase 3 trial of Celcuity’s breast cancer combination has hit its p…